SummitTX Capital L.P. Invests $4.27 Million in Envista Holdings Corporation $NVST

SummitTX Capital L.P. acquired a new stake in Envista Holdings Corporation (NYSE:NVST) in the 1st quarter, Holdings Channel reports. The firm acquired 168,244 shares of the company’s stock, valued at approximately $4,268,000.

Several other hedge funds and other institutional investors have also modified their holdings of NVST. Dimensional Fund Advisors LP increased its position in Envista by 1.6% during the first quarter. Dimensional Fund Advisors LP now owns 9,780,948 shares of the company’s stock worth $248,130,000 after acquiring an additional 152,488 shares during the period. Alliancebernstein L.P. boosted its holdings in Envista by 34.0% in the 2nd quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock valued at $119,164,000 after purchasing an additional 1,547,656 shares during the period. Massachusetts Financial Services Co. MA boosted its holdings in Envista by 15.3% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 3,349,874 shares of the company’s stock valued at $72,726,000 after purchasing an additional 444,725 shares during the period. Arrowstreet Capital Limited Partnership grew its position in Envista by 341.5% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,858,293 shares of the company’s stock worth $72,515,000 after purchasing an additional 2,210,847 shares during the last quarter. Finally, Millennium Management LLC grew its position in Envista by 1,442.7% in the 4th quarter. Millennium Management LLC now owns 2,420,615 shares of the company’s stock worth $52,552,000 after purchasing an additional 2,263,712 shares during the last quarter.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on NVST shares. Citigroup started coverage on shares of Envista in a research report on Wednesday, April 15th. They set a “neutral” rating and a $29.00 price objective for the company. Wall Street Zen downgraded Envista from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 9th. Evercore restated an “outperform” rating and set a $33.00 price target on shares of Envista in a research note on Thursday, May 7th. JPMorgan Chase & Co. upped their price target on Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Finally, Weiss Ratings downgraded Envista from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. Six equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $28.54.

Envista Stock Performance

Envista stock opened at $26.64 on Tuesday. The firm has a market capitalization of $4.34 billion, a P/E ratio of 64.99, a P/E/G ratio of 1.49 and a beta of 0.86. The stock has a fifty day moving average price of $25.26 and a two-hundred day moving average price of $25.79. Envista Holdings Corporation has a 52-week low of $18.77 and a 52-week high of $30.42. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.44 and a quick ratio of 2.06.

Envista (NYSE:NVST) last issued its earnings results on Wednesday, May 6th. The company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.31 by $0.05. Envista had a net margin of 2.41% and a return on equity of 7.11%. The company had revenue of $705.50 million for the quarter, compared to the consensus estimate of $680.03 million. During the same quarter in the previous year, the company earned $0.24 EPS. The firm’s revenue for the quarter was up 14.4% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. As a group, analysts anticipate that Envista Holdings Corporation will post 1.42 EPS for the current fiscal year.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.